 "Thyrocare raises Rs 144 cr from anchor investors")
Shares of Thyrocare Technologies moved higher by 10 per cent to Rs 769 on the BSE in Thursday's intra-day trade in an otherwise weak market. In the past two trading days, the stock of healthcare service provider has surged 26 per cent amid the fresh Covid-19 scare, as Covid cases soar in China.
Thyrocare is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that centre on early detection and management of health disorders and diseases.
In the private sector, Thyrocare is the pioneers in offering an entire
Thyrocare is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that centre on early detection and management of health disorders and diseases.
In the private sector, Thyrocare is the pioneers in offering an entire
